Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W M Prodinger

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Immunologic Research|March 31, 2000
Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trappingW M Prodinger
Wiener Klinische Wochenschrift|January 1, 1993
[Infective pathogens as a possible etiology of idiopathic peripheral facial paralysis]D Imarhiagbe, W M Prodinger, E Schmutzhard
Current Topics in Microbiology and Immunology|January 1, 1990
C3 binding proteins of foreign originM P Dierich, H P Huemer, W M Prodinger
Emerging Infectious Diseases|June 1, 2001
Mycobacterium tuberculosis isolates of Beijing genotype in ThailandW M Prodinger, P Bunyaratvej, R Prachaktam, et al.
Journal of Clinical Microbiology|November 24, 1999
Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent hostM Pavlic, F Allerberger, M P Dierich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell linesW M Prodinger, C Larcher, M Schwendinger, et al.
Wiener Klinische Wochenschrift|January 1, 1993
Early diagnosis of perinatally acquired HIV infection by the polymerase chain reactionE Puchhammer-Stöckl, F X Heinz, W M Prodinger, et al.
Experimental and Clinical Immunogenetics|January 1, 1995
Complement C7 M/N allotyping in infectious diseasesR Würzner, B M Sölder, W M Prodinger, et al.
Immunology|March 20, 2002
CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytesC H Nielsen, H V Marquart, W M Prodinger, et al.
Infection|March 1, 1990
Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addictsH P Huemer, W M Prodinger, C Larcher, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Immunologic Research|March 31, 2000
Complement receptor type two (CR2,CR21): a target for influencing the humoral immune response and antigen-trappingW M Prodinger
Wiener Klinische Wochenschrift|January 1, 1993
[Infective pathogens as a possible etiology of idiopathic peripheral facial paralysis]D Imarhiagbe, W M Prodinger, E Schmutzhard
Current Topics in Microbiology and Immunology|January 1, 1990
C3 binding proteins of foreign originM P Dierich, H P Huemer, W M Prodinger
Emerging Infectious Diseases|June 1, 2001
Mycobacterium tuberculosis isolates of Beijing genotype in ThailandW M Prodinger, P Bunyaratvej, R Prachaktam, et al.
Journal of Clinical Microbiology|November 24, 1999
Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent hostM Pavlic, F Allerberger, M P Dierich, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1996
Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell linesW M Prodinger, C Larcher, M Schwendinger, et al.
Wiener Klinische Wochenschrift|January 1, 1993
Early diagnosis of perinatally acquired HIV infection by the polymerase chain reactionE Puchhammer-Stöckl, F X Heinz, W M Prodinger, et al.
Experimental and Clinical Immunogenetics|January 1, 1995
Complement C7 M/N allotyping in infectious diseasesR Würzner, B M Sölder, W M Prodinger, et al.
Immunology|March 20, 2002
CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytesC H Nielsen, H V Marquart, W M Prodinger, et al.
Infection|March 1, 1990
Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addictsH P Huemer, W M Prodinger, C Larcher, et al.
Pageof 4